413 related articles for article (PubMed ID: 29332041)
1. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
[TBL] [Abstract][Full Text] [Related]
2. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models.
Ni R; Ji B; Ono M; Sahara N; Zhang MR; Aoki I; Nordberg A; Suhara T; Higuchi M
J Nucl Med; 2018 Jun; 59(6):960-966. PubMed ID: 29419480
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy.
Fairley LH; Sahara N; Aoki I; Ji B; Suhara T; Higuchi M; Barron AM
J Neuroinflammation; 2021 Mar; 18(1):76. PubMed ID: 33740987
[TBL] [Abstract][Full Text] [Related]
4. Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy.
Sahara N; Maeda J; Ishikawa A; Tokunaga M; Suhara T; Higuchi M
J Alzheimers Dis; 2018; 64(s1):S353-S359. PubMed ID: 29865054
[TBL] [Abstract][Full Text] [Related]
5. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.
Endepols H; Anglada-Huguet M; Mandelkow E; Schmidt Y; Krapf P; Zlatopolskiy BD; Neumaier B; Mandelkow EM; Drzezga A
Mol Neurobiol; 2022 Jun; 59(6):3402-3413. PubMed ID: 35312967
[TBL] [Abstract][Full Text] [Related]
7. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
Maeda J; Zhang MR; Okauchi T; Ji B; Ono M; Hattori S; Kumata K; Iwata N; Saido TC; Trojanowski JQ; Lee VM; Staufenbiel M; Tomiyama T; Mori H; Fukumura T; Suhara T; Higuchi M
J Neurosci; 2011 Mar; 31(12):4720-30. PubMed ID: 21430171
[TBL] [Abstract][Full Text] [Related]
8. Characterization of
Weng CC; Hsiao IT; Yang QF; Yao CH; Tai CY; Wu MF; Yen TC; Jang MK; Lin KJ
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290239
[TBL] [Abstract][Full Text] [Related]
9. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.
Maruyama M; Shimada H; Suhara T; Shinotoh H; Ji B; Maeda J; Zhang MR; Trojanowski JQ; Lee VM; Ono M; Masamoto K; Takano H; Sahara N; Iwata N; Okamura N; Furumoto S; Kudo Y; Chang Q; Saido TC; Takashima A; Lewis J; Jang MK; Aoki I; Ito H; Higuchi M
Neuron; 2013 Sep; 79(6):1094-108. PubMed ID: 24050400
[TBL] [Abstract][Full Text] [Related]
10. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
[TBL] [Abstract][Full Text] [Related]
11. A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model.
Kimura T; Ono M; Seki C; Sampei K; Shimojo M; Kawamura K; Zhang MR; Sahara N; Takado Y; Higuchi M
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4298-4311. PubMed ID: 35798978
[TBL] [Abstract][Full Text] [Related]
12. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases.
Biechele G; Franzmeier N; Blume T; Ewers M; Luque JM; Eckenweber F; Sacher C; Beyer L; Ruch-Rubinstein F; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Cumming P; Bartenstein P; Rominger A; Höglinger GU; Herms J; Brendel M
J Neuroinflammation; 2020 Dec; 17(1):374. PubMed ID: 33317543
[TBL] [Abstract][Full Text] [Related]
13. In vivo positron emission tomography imaging of mitochondrial abnormalities in a mouse model of tauopathy.
Barron AM; Ji B; Fujinaga M; Zhang MR; Suhara T; Sahara N; Aoki I; Tsukada H; Higuchi M
Neurobiol Aging; 2020 Oct; 94():140-148. PubMed ID: 32623260
[TBL] [Abstract][Full Text] [Related]
14. PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury.
Takahata K; Kimura Y; Sahara N; Koga S; Shimada H; Ichise M; Saito F; Moriguchi S; Kitamura S; Kubota M; Umeda S; Niwa F; Mizushima J; Morimoto Y; Funayama M; Tabuchi H; Bieniek KF; Kawamura K; Zhang MR; Dickson DW; Mimura M; Kato M; Suhara T; Higuchi M
Brain; 2019 Oct; 142(10):3265-3279. PubMed ID: 31504227
[TBL] [Abstract][Full Text] [Related]
15. MK-8719, a Novel and Selective
Wang X; Li W; Marcus J; Pearson M; Song L; Smith K; Terracina G; Lee J; Hong KK; Lu SX; Hyde L; Chen SC; Kinsley D; Melchor JP; Rubins DJ; Meng X; Hostetler E; Sur C; Zhang L; Schachter JB; Hess JF; Selnick HG; Vocadlo DJ; McEachern EJ; Uslaner JM; Duffy JL; Smith SM
J Pharmacol Exp Ther; 2020 Aug; 374(2):252-263. PubMed ID: 32493725
[TBL] [Abstract][Full Text] [Related]
16. In vivo binding of a tau imaging probe, [
Endo H; Shimada H; Sahara N; Ono M; Koga S; Kitamura S; Niwa F; Hirano S; Kimura Y; Ichise M; Shinotoh H; Zhang MR; Kuwabara S; Dickson DW; Toda T; Suhara T; Higuchi M
Mov Disord; 2019 May; 34(5):744-754. PubMed ID: 30892739
[TBL] [Abstract][Full Text] [Related]
17. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
[TBL] [Abstract][Full Text] [Related]
19. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
